Clinical Trial Update: A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety of BIIB080 injections and whether they can improve cognitive symptoms in adults aged 50-80 with mild cognitive im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Dementia
• Cognitive Impairment Due to Alzheimer Disease

Drugs mentioned

• BIIB080

Snippet

Sponsor: Biogen | Conditions: Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia | Phase 2 | Status: ACTIVE_NOT_RECRUITING